| Affected Systems |
|
|
|
|
|
|
cardiovascular system
|
N
|
√
|
√
|
√
|
|
cardiovascular system phenotype
|
N
|
|
|
|
|
pharyngeal arch artery hypoplasia
|
|
√
|
√
|
√
|
|
persistent truncus arteriosus
|
|
√
|
√
|
√
|
|
decreased heart left ventricle wall thickness
|
|
√
|
√
|
√
|
|
increased vascular permeability
|
|
√
|
√
|
√
|
craniofacial
|
√
|
√
|
√
|
√
|
|
pharyngeal arch artery hypoplasia
|
|
√
|
√
|
√
|
|
flat forehead
|
√
|
√
|
√
|
√
|
|
facial cleft
|
√
|
|
|
|
embryo
|
|
√
|
√
|
√
|
|
pharyngeal arch artery hypoplasia
|
|
√
|
√
|
√
|
growth/size/body
|
√
|
√
|
√
|
√
|
|
flat forehead
|
√
|
√
|
√
|
√
|
|
facial cleft
|
√
|
|
|
|
mortality/aging
|
√
|
√
|
√
|
√
|
|
lethality throughout fetal growth and development
|
√
|
√
|
√
|
√
|
|
embryonic lethality during organogenesis, complete penetrance
|
|
√
|
√
|
√
|